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Summary box
 ► Priority setting for health research aims to ensure 
appropriate and efficient resource allocation and 
use, especially in resource-constrained areas.
 ► Subregional priority setting activities using a mix of 
approaches has led to the identification of contem-
porary, contextual and region-specific health priori-
ties for systematic reviews.
 ► Embedding systematic review workshops helps 
stakeholders such as researchers, policy-makers, 
healthcare professionals, programme managers to 
discuss questions and prioritise topics in an infor-
mative way.
 ► Emerging priorities may be missed if only one bur-
den of disease database is used, and self-selection 
of stakeholders and language differences can be an 
important barrier in some regions.
 ► A wide range of approaches that acknowledge lan-
guage and cultural differences should be explored.
AbSTrACT
Priority setting to identify topical and context relevant 
questions for systematic reviews involves an explicit, 
iterative and inclusive process. In resource-constrained 
settings of low-income and middle-income countries, 
priority setting for health related research activities 
ensures efficient use of resources. In this paper, we 
critically reflect on the approaches and specific processes 
adopted across three regions of Africa, present some of 
the outcomes and share the lessons learnt while carrying 
out these activities. Priority setting for new systematic 
reviews was conducted between 2016 and 2018 across 
three regions in Africa. Different approaches were used: 
Multimodal approach (Central Africa), Modified Delphi 
approach (West Africa) and Multilevel stakeholder 
discussion (Southern-Eastern Africa). Several questions 
that can feed into systematic reviews have emerged 
from these activities. We have learnt that collaborative 
subregional efforts using an integrative approach can 
effectively lead to the identification of region specific 
priorities. Systematic review workshops including 
discussion about the role and value of reviews to inform 
policy and research agendas were a useful part of the 
engagements. This may also enable relevant stakeholders 
to contribute towards the priority setting process in 
meaningful ways. However, certain shared challenges 
were identified, including that emerging priorities may 
be overlooked due to differences in burden of disease 
data and differences in language can hinder effective 
participation by stakeholders. We found that face-to-face 
contact is crucial for success and follow-up engagement 
with stakeholders is critical in driving acceptance of the 
findings and planning future progress.
InTroduCTIon
Stakeholder-informed priority setting for 
health research helps to identify topical 
and relevant issues and their accompanying 
unresolved questions regarding prevention, 
diagnosis, treatment, prognosis and reha-
bilitation using an explicit, iterative and 
inclusive process.1 In addition, it should 
ensure the efficient use of scarce resources 
in both the design and implementation of 
programmes to address relevant health-
care issues for measurable regional and 
country-wide impact.2 Countries in sub-Sa-
haran Africa are presently facing the twin 
problems of resource constraints and high 
disease burden and therefore priority setting 
is an essential component of resource allo-
cation. Although the region still has high 
mortality and morbidity from infectious 
diseases such as HIV infection, tuberculosis 
(TB), malaria and lately viral haemorrhagic 
fevers, non-communicable diseases (NCDs) 
now account for a substantial proportion of 
those deaths and morbidities.3 Indeed, it is 
projected that by 2030, NCDs will account for 
thrice the disability-adjusted life years world-
wide and about five times the combined 
mortality from infectious, nutritional as well 
as maternal and perinatal diseases in African 
countries.4 This disproportionate occurrence 
will place enormous strain on already over-
burdened and fragile health systems in these 
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Figure 1 Priority setting process in West Africa Hub. PICO, 
Participants, Intervention, Comparison, Outcome. RCTs, 
Randomised Controlled Trials.
Figure 2 Priority setting process in Francophone hub.
countries. As such, evidence on efficient strategies to 
prevent and manage NCDs are needed to inform policy 
and practice.
In line with Cochrane’s ‘Strategy to 2020’, several 
Cochrane groups have undertaken priority setting with 
a view to a more efficient use of resources for research 
synthesis, including a mix of formal and informal 
approaches.5 6 Although these approaches have been 
successful in identifying high priority topics,7 the views 
of African stakeholders have not been adequately repre-
sented. Consequently, questions relevant to the African 
context may not have been considered in the list of 
priority titles for systematic reviews that have emerged 
from these efforts. Given the dearth of human resources 
for health, poor health services financing, suboptimal 
deployment of life saving technology and essential 
medicines, as well as a complex mix of socioeconomic, 
cultural, gender and equity disparities across many of 
Africa’s health systems, it is reasonable to undertake 
priority setting at this time to answer the accompanying 
unresolved questions.
Although there is no gold standard framework, there are 
common principles about what constitutes good practice 
in setting priorities. These include the use of an explicit 
process, stakeholder engagement, information manage-
ment, consideration of values and context as well as 
having mechanisms in place for reviewing decisions.8 9 To 
ensure credible outcomes, any specific approach should 
allow a transparent, inclusive and iterative process.10 The 
reliance on interpretive assessments using stakeholder 
(eg, consumers, healthcare practitioners, policy-makers) 
driven consensus dialogues should lead to relevant ques-
tions and subsequent implementation of the findings.11
Cochrane Africa is a network of institutions and 
researchers committed to supporting the production 
and use of context relevant priority systematic reviews to 
inform healthcare decision-making in the sub-Saharan 
region for optimum impact.12 Cochrane Africa comprises 
three hubs: West Africa, Francophone and South-
ern-Eastern (SE) hubs. These hubs have been involved in 
priority setting efforts in the past.13 14 Recently, hub-spe-
cific priority setting activities for systematic reviews took 
place in three African regions within this network. In 
this paper, we critically examine the various approaches 
used, share the results of the scoping of the literature to 
identify gaps in the evidence base, compare the various 
processes adopted and discuss the lessons learnt from 
implementing these independent priority setting activi-
ties across the region.
IdenTIfyIng prIorITIeS for new SySTemATIC revIewS
We conducted tailored priority setting in 2016 in Came-
roon (Central Africa); in 2017 in Nigeria, Liberia, Ghana 
and Sierra-Leone (West Africa) and in 2017 in Kenya 
and South Africa (Southern-Eastern Africa). Specific 
approaches undertaken by each hub are described below. 
They are described separately but there are core elements 
that are common across the three approaches.
modified delphi approach
In the West African hub, a combination of methods, 
including a modified Delphi process and some of those 
identified by the Cochrane priority setting methods 
group,15 were used in an iterative way. The Delphi 
process involved two rounds of prioritisation where 
key stakeholders in the first round indicated top prior-
ities via email and in the second round, were asked to 
add to the list just before stakeholder discussions. The 
Cochrane methods group identifies authors of systematic 
reviews as stakeholders in the process hence our deci-
sion to involve them. Electronic and face-to-face contacts 
with key informants were done at various stages of the 
process across four countries namely Nigeria, Liberia, 
Ghana and Sierra Leone. The stakeholders were selected 
based on their involvement with Cochrane activities in 
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Figure 3 Priority setting process in the Southern-Eastern hub.
their region, links or involvement with disease control 
programmes, expertise in communicable and NCDs 
and work in specific disease areas. First, using the global 
burden of disease (GBD) data for 2016, national priority 
conditions across the region were identified.16 These were 
ranked by key informants from the Cochrane network 
including Cochrane authors and by health policy-makers 
and managers of disease control programmes across the 
region based on the importance of the condition and 
their knowledge of the prevalence and incidence. The key 
informants were requested to add any other health condi-
tion not on the country-specific GBD list but which was 
considered important. Twenty-nine stakeholders across 
Nigeria (12), Liberia (11) and Ghana and Sierra Leone (1 
each) responded to the initial ranking of priority disease 
conditions. Stakeholder panels were held in Nigeria and 
Liberia to formulate questions using the PICO (Partici-
pants, Intervention, Comparison, Outcome) tool guided 
by a framework that focused on prevention, diagnostics, 
treatment and rehabilitation. This resulted in a list of 164 
questions that cut across 4 health categories. An online 
survey tool was used to circulate the 164 review questions 
to stakeholders in Anglophone West Africa (Gambia, 
Sierra Leone, Liberia, Ghana and Nigeria) for scoring. 
Eighty-eight (63%) out of 140 stakeholders responded to 
the request to rank priority review questions. Each stake-
holder gave a score (0–5) to each question using largely 
a priori factors namely the prevalence of the condition, 
the likelihood the condition will cause death or disability, 
cost effectiveness, the likelihood of the intervention 
improving health outcomes and feasibility of the inter-
vention. Based on these scores, the review title with the 
highest score was ranked first resulting in 25 questions 
being nominated.
Following this, online databases (CENTRAL, MEDLINE 
(PubMed) and clinical trial registries) were searched in 
October 2017 for existing systematic reviews and clin-
ical trials addressing identified questions. The search 
retrieved 3608 records, of which 24 were systematic 
reviews and 43 were randomised controlled trials. Two 
researchers independently screened, selected studies for 
inclusion and conducted data extraction. And discrepan-
cies were resolved by a senior researcher. An analysis of 
the outputs was done to identify gaps for new reviews or 
those requiring updates. The process is shown in figure 1.
multimodal approach
This was the approach adopted by the Francophone hub, 
coordinated from Cameroon. Here, the priority setting 
process started in 2016, identifying and merging national 
health priorities with those of the Effective Healthcare 
Research Consortium (EHCRC, http://www. evidence-
4health. org). The EHCRC focuses on ensuring relevant 
and priority healthcare problems such as malaria, TB, 
child and maternal health conditions in low-income 
and middle-income countries (LMICs) are addressed 
in systematic reviews.17 The key steps are as shown in 
figure 2 and listed below:
1. Identifying relevant stakeholders (researchers, aca-
demics, clinicians, journalists, civil society organisa-
tions, ministry of health (MOH), non-governmental 
organisations (NGOs) and so on).
2. Creating a list of email and office addresses for select-
ed stakeholders.
3. Developing an initial (non-exhaustive) list of priorities 
based on documented causes of mortality/morbidity 
from the GBD data for Cameroon and funder (EH-
CRC) priorities (essentially diseases of the poor espe-
cially affecting women).
4. Conducting systematic review workshops for clinicians 
and other stakeholders to build capacity on the evi-
dence generation process.
5. Sharing the initial list of priorities with stakeholders 
with a request to rank them from 1 to 10, with one be-
ing the least priority and 10 being the highest priority. 
A total of 72 stakeholders in the city of Yaoundé were 
approached. They included 30 clinician/researchers, 
26 clinicians, 1 IT expert, 7 researchers, 1 journal ed-
itor, 3 MOH representatives and 4 representatives of 
NGOs. Responses were collected in two ways:
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Table 1 Priority topics identified through priority setting processes across the three hubs
CAN hub Priority topic/Question Current status
West African Community-based vs facility-based directly observed intermittent 
preventive therapy in pregnancy for preventing malaria
Registered with PROSPERO
Booster dose of Bacille Calmette-Guerin vaccine for preventing 
tuberculosis in LMICs
Registered with PROSPERO
Mass deworming or targeted deworming for preventing or treating 
anaemia or improving nutritional status and cognition in children
  –
Cognitive behavioural therapy plus pharmacological therapy versus 
pharmacological therapy for vaso-occlusive pain in children with 
sickle cell
  –
Early screening for preventing breast cancer   –
Public health education for preventing breast cancer   –
  Hand hygiene for preventing infections in neonates Registered with Cochrane Neonatal 
Review Group
Self-breast examination for preventing cancer   –
Francophone Effects of structured antiretroviral therapy treatment interruptions in 
chronic suppressed HIV-infected African adults
  –
  Pattern of cardiovascular disease in African patients with chronic 
renal failure
  –
  Cost-effectiveness of Procalcitonin in the follow-up of bacterial 
infections
  –
  Prevalent pulmonary embolism, mortality rate, disease determinants 
and predictors of mortality following non-cardiac surgery in sub-
Saharan Africans
  –
Southern-Eastern In patients with ESRD, what are the effects of different frequency (eg, 
thrice vs twice per week dialysis) or duration of dialysis (eg, 3 hours 
vs 4.5 hours) on quality of life and cost-effectiveness outcomes?
Title registered with Cochrane Renal 
and Transplant Review as ‘Less 
intensive vs conventional haemodialysis 
for people with end-stage kidney 
disease’
  Among adult patients on haemodialysis with intradialytic 
hypotension, what are the effects of changing dialysate sodium on 
reducing intradialytic hypotension?
  –
CAN, Cochrane Africa Network; ESRD, end stage renal disease; LMICs, low-income and middle-income countries.
i. via email; requested within 3 weeks from all stake-
holders and
ii. via door-to-door visits; for stakeholders within the 
city of Yaoundé who did not respond by email 
(mostly academics, ministry staff, clinicians and 
members of civil society organisations).
6. Identifying existing systematic reviews addressing top 
priority topics, defined by the highest mean rank.
7. Producing evidence assessments/translations of sys-
tematic reviews addressing top priority topics.
multilevel stakeholder discussion
In the SE hub, the priority setting process involved coun-
tries in East Africa, with support from South Africa. 
The process started with the identification of a specific 
and often neglected priority field—chronic kidney 
disease—and approaching relevant decision-makers 
in that field. These included the Cochrane Kidney and 
Transplant Review Group (http:// kidneyandtransplant. 
cochrane. org) and the Kenya Renal Association. The 
SE hub co-conducted two workshops in Nairobi in June 
and July 2017, with healthcare professionals and other 
decision makers working in the renal field. During the 
first workshop, which were attended by 32 participants 
including nephrology registrars, medical officers and 
pharmacists, the importance and steps of evidence-based 
healthcare and systematic reviews were introduced. The 
second workshop started with introduction to phrasing 
questions using the PICO tool and the importance of 
priority setting, whereafter participants were asked to 
generate questions they feel are important for their local 
research agenda. Twenty-five participants attended the 
second workshop, of which 19 had also attended the first 
workshop. Among the participants were eight physicians 
undertaking a fellowship in nephrology and a senior poli-
cy-maker from the Kenya Ministry of Health. They gener-
ated 30 questions which we grouped into the different 
types of questions (eg, questions on interventions, 
burden of disease, risk factors and so on). Subsequently, 
through engagement with two key kidney care specialists 
in the region, we compiled a short-list of six questions 
based on their expert opinions. Literature searches in the 
Cochrane Database of Systematic Reviews and MEDLINE 
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Table 2 Comparison of processes, findings and lessons learnt
Domain West Africa hub Francophone hub Southern-Eastern hub
Focus Communicable and non-
communicable diseases
Infectious diseases and 
diseases of poverty
Specific disease field—chronic 
kidney disease
Process Modified Delphi Multimodal approach Multilevel stakeholder 
discussions
Stakeholders involved Cochrane (internal) and non-
Cochrane (external) including 
patients and consumer groups
Mainly non-Cochrane, key 
policy makers, clinicians, 
researchers
Professional group (Renal 
Association), specialists in the 




Modified Delphi involving virtual 
contacts and face-face group 
discussions
Electronic, one-on-one contact 
and group discussions
In-person and virtual group 
discussions
Feasibility Fewer or non-existent Cochrane 
stakeholders in many countries of 
the region
Language barrier—
engagements in two languages,
Single country involvement 
in some steps of the process 
and wider consultations 
subsequently
Value-added Involvement of patients and 
consumers. Workshop in 
systematic reviews
In-person contact of policy 
makers. Workshop in 
systematic reviews
Involvement of Cochrane 
Review Group and workshop in 
evidence-based healthcare and 
systematic reviews
Cost More expensive holding 
stakeholder discussions across 
countries—so limited to two only 
(Nigeria and Liberia)
Cost savings as only 
stakeholders in Cameroon 
involved
Cost savings likely as 
stakeholder discussions for 
prioritisation of topics held 
virtually
Outcome Priority review topics and 
registration
Translation and dissemination 
of Evidence Assessments
Title registration of a priority 
question with the Cochrane 
Kidney and Transplant Group
Weakness Fewer or non-existent Cochrane 
stakeholders in many countries of 
the region
Language barrier—
engagements in two languages, 
limited
Single country involvement 
in some steps of the process 
and wider consultations 
subsequently
(PubMed) were then conducted in October 2017 for 
existing reviews answering these questions. A search 
was conducted for each of the six short-listed questions. 
After screening titles and abstracts of retrieved records 
results by one researcher, 11 relevant systematic reviews, 
including 3 Cochrane reviews, were found. Evidence 
mapping (using the PICO format) of existing systematic 
reviews was conducted to identify the gaps in the current 
literature. After further discussion with experts and the 
Cochrane Kidney Transplant Review Group virtually, two 
questions, for which there was an evidence-gap, were 
identified (see table 1). It was agreed that the question 
of haemodialysis frequency and duration in patients with 
end-stage kidney disease was of high priority. An author 
team was put together and the title registered with the 
review group. The step by step process is presented in 
figure 3.
prIorITy TopICS IdenTIfIed
Although the approaches have been different, the 
outcomes reflect region-specific priorities. Some of the 
priority questions, titles and topics are listed in table 1.
proCeSSeS, fIndIngS And leSSonS leArned
Our core objective as Cochrane Africa is to support 
the production of context relevant priority reviews that 
can inform policy and practice in the region. In many 
settings, arriving at what constitutes priority questions has 
been influenced by locoregional factors including socio-
cultural factors, available resources, burden of disease, 
nature of the health system as well as its financing.18 
Often, the research agenda and the research priorities 
are set by global funders and multilateral agencies19 and 
may appear to limit the inclusion of value and equity 
issues relevant to those countries. Cochrane Africa’s work 
has demonstrated that a variety of approaches can lead 
to successful identification of priority review topics.7 We 
have summarised the comparisons of the processes, find-
ings and lessons learnt in table 2.
Comparison of processes
Priority setting in resource poor settings of LMICs rely 
extensively on frameworks that make use of burden of 
disease data and cost effectiveness analysis, strategies 
that have been found to reasonably influence policies 
downstream.20 In the West African and Francophone 
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hubs, these two frameworks have influenced decisions to 
prioritise particular conditions both in terms of identifi-
cation of priority diseases and the ranking of questions 
that emerged from the process. This may have led to the 
exclusion of other priorities. For example, the use of the 
GBD data in the initial identification of prevalent condi-
tions in the West African hub instead of data from the 
national bureau of statistics may have led to the exclusion 
of conditions such as trauma and mental health disorders. 
This limitation was resolved by asking the key informants 
to add any health condition they considered important 
but not on the original list of disease conditions extracted 
from country-specific GBD circulated. Furthermore, as 
the prioritisation process was across some countries of 
West Africa, GBD data were chosen to ensure consistency 
across the region. For the Francophone hub, the GBD 
data were the most up-to-date and reliable database with 
emphasis on diseases of poverty which was the focus of 
the funder. For Southern Eastern hub, the field of prior-
itisation was chosen based on feasibility and prior profes-
sional relationship with the renal community.
The processes had to be undertaken in two languages 
(French and English) in Cameroon. Language barriers 
pose a substantial challenge to effective dissemina-
tion and potential uptake of research evidence. Until 
recently, most research was only available in English 
language, thereby limiting access and use. Cochrane 
now has a multilanguage strategy as part of its transla-
tion efforts. It is expected that this initiative will improve 
access to research publications, increase capacity for use 
of research evidence and scale up impact in countries 
where English is not a native language.
Stakeholder involvement is essential and may serve 
to narrow questions to very critical areas and to save on 
resources needed for the entire priority setting process. 
It also enhances uptake of evidence.21 The strategy of 
engagement of stakeholders may be determined by avail-
able resources and in our case varied across the hubs. In 
the West African hub, the modified Delphi process was 
used across two countries and involved key consumer 
groups and patients apart from Cochrane authors, editors 
and so on. In the SE hub, a key professional group was 
engaged using face-to-face group meetings and virtually 
for ranking of priority topics while in the Francophone 
hub, key policy-makers were involved and engaged virtu-
ally (via email) and through one-on-one in-person meet-
ings. Across all three hubs, systematic review workshops 
were embedded into the process. These enabled intro-
duction of participants to the concepts and relevance 
of evidence-based healthcare and systematic reviews 
and allowed for informed discussions and prioritisation 
of topics. Capacity building efforts such as these are 
ongoing in the region.22 Stakeholder involvement makes 
for a transparent process and in an appropriate setting 
prevents domination of one group over the other.23 
Furthermore, engaging a wide variety of stakeholders 
in the generation of evidence has also been shown to 
enhance end-user participation as well as identification 
of appropriate policy opportunities and likely direction 
of political support. Even in the adhoc policy environ-
ment in LMICs, stakeholder participation has a potential 
to be useful.24 The door-to-door model of stakeholder 
engagement proved to be useful in the Francophone hub 
although it required enormous resources to organise and 
limited the scope of stakeholders that could be reached.
A key concern when embarking on any priority setting 
exercise is to determine what resources are available for 
the scope of work ahead. For Cochrane, the involvement 
of both internal (authors, editors, consumers and so 
on) and external (policy-makers, clinicians, NGOs and 
so on) stakeholders in the priority setting process leads 
to useful partnerships and empowerment and ensures 
successful outcomes.6 This has been demonstrated across 
all three Cochrane Africa Network (CAN) hubs. We did 
not appraise the cost of the entire activity but presume 
that our use of electronic and face-to-face meetings in the 
West African and Southern Eastern hubs may have led to 
some cost savings.
Comparison of findings
The outcomes of the different priority setting exercises 
were varied. Several priority topics across preventative, 
diagnostic and therapeutic interventions were identi-
fied, and systematic reviews addressing some of these 
are underway with the relevant Cochrane review groups. 
The topics also varied because the different hubs had a 
different focus at the start of the process. Whereas the 
West African hub focused on a wide range of commu-
nicable and NCDs, the Francophone hub focused on 
diseases of poverty and the South-Eastern hub focused 
on a single NCD—chronic kidney disease. Owing to 
language concerns, the prioritisation efforts in the Fran-
cophone hub focused on identifying relevant existing 
reviews to help with the production of bilingual evidence 
summaries for wider dissemination, access and use by 
various stakeholders.
lessons learnt
Lessons have been learnt following an assessment of the 
implementation of priority setting activities across the 
Cochrane Africa hubs. This involved examining the various 
approaches, comparing them, reflecting on the strengths 
and weaknesses and drawing lessons for future activities. 
Although the approaches have been different, the outcomes 
reflect region-specific priorities. The iterative nature of the 
approaches underscores the need to allow for an open and 
transparent process. Leveraging existing burden of disease 
data or other regional or national diseases burden data is a 
useful step but needs to allow for input from stakeholders 
on the ground. Focused priority setting on a single disease 
field and working with key stakeholders identified during 
the preparatory phase ensures that the outcomes are also 
focused and acceptable.
Stakeholder involvement across the entire process is 
a sine qua non for successful outcomes that reflect the 
health priorities of the regions in addition to enhancing 
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evidence uptake. Indeed, stakeholder engagement and 
improved understanding of the prioritisation process has 
been identified as a key indicator of successful priority 
setting activities.8 9 For optimal impact, across all three 
hubs, stakeholders were selected based on their affilia-
tion with Cochrane, work in an area of focus and capacity 
to influence policies. The engagement strategies have 
varied with the type of stakeholders and have been influ-
enced by availability of resources. In the West African 
hub, we observed that patients tended to prioritise inter-
ventions for disease prevention rather than treatment. 
Patient involvement has been noted to increase the cost of 
prioritisation process and the time to reach consensus.25 
However, in the West Africa hub, where patients and 
consumer groups have been involved, we did not study 
this directly. We think that the cost was not affected but 
time to reach consensus may have increased presumably 
because more time was spent to explain some concepts 
and the process to patient participants.
Although time-consuming and resource intensive, 
door-to-door meetings to obviate poor access to internet 
have proven to be useful. Finally, for Cochrane, the 
involvement of the appropriate Cochrane editorial group 
remains imperative to ensure a pipeline for conducting 
new Cochrane Reviews.
ConCluSIon
Priority setting is an iterative process, with issues emerging 
over time, and different approaches may be used to elicit 
region-relevant priorities. Through Cochrane Africa’s 
priority setting processes, we learnt that emerging prior-
ities may be missed because of the drawn out process, 
that stakeholder involvement is critical to the success of 
the priority setting process, that face-to-face contact and 
follow-up after engaging with stakeholders is important, 
and that language can be a barrier across the entire spec-
trum of activities.
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